Virax adds myeloma expert to scientific board

Virax Holdings (ASX:VHL) has now added a multiple myeloma expert to its scientific advisory board, after picking a breast cancer expert in July. [+]

> Posted in Health & medical on 23 September, 2014

Clinuvel enters dermatology drug JV

Clinuvel (ASX:CUV) will form a joint venture with Biotech Lab Singapore to develop paediatric versions of Scenesse and a new dermatology drug candidate.

[+]

> Posted in Biotechnology on 22 September, 2014

R&D Tax Incentive - overseas R&D activities update

An update for companies on what "not available in Australia" means for meeting the requirements to make a claim for R&D activities conducted outside of... [+]

> Posted in Biotechnology on 17 September, 2014

Simavita's US partner wins first big contract

Simavita's (ASX:SVA) exclusive US distribution partner Medline has picked up its first major supply contract for the Smart Incontinence Management (SIM) medical device. [+]

> Posted in Biotechnology on 16 September, 2014

GTG restructures to focus on molecular diagnosis

Genetic Technologies (ASX:GTG) has announced a restructuring project, as well as plans to launch the upgraded version of breast cancer risk test BREVAGen next month. [+]

> Posted in Molecular biology on 15 September, 2014

Latest News

Awards for translational research

A national prize and four awards are being offered by the Translation Research Institute to... [+]

> Posted in Health & medical

Bionomics buying France's Prestwick Chemical

Bionomics (ASX:BNO) is buying Prestwick Chemical, a medicinal chemistry services provider... [+]

> Posted in Biotechnology

Delegation to BIO stamps Australia as a world leader in biotech

This year, Australia stamped its presence on the 2014 BIO International Convention with more... [+]

> Posted in Biotechnology

GTG selling Australian genetics business

Genetic Technologies (ASX:GTG) will sell its Australian genetics testing business to a Primary... [+]

> Posted in Molecular biology

Starpharma raising $23m for clinical programs

Starpharma (ASX:SPL) is conducting an up-to $23m placement and plans to use part of the proceeds... [+]

> Posted in Health & medical

Click here for your FREE subscription

Lab+Life Scientist: The Magazine

Lab+Life Scientist - the magazine for Australia’s scientific and research leaders and innovators. Click for your FREE subscription